Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - fluvoxamine maleate - tablets - fluvoxamine maleate 100 mg - fluvoxamine - fluvoxamine - for the treatment of affective disorders characterized by persistent low mood, impaired psychomotor atctivities and psychomatic complaints including symptoms of depression. treatment of obsessive compulsive disorders (ocd).

Israel - English - Ministry of Health

eli lilly israel ltd, israel - teriparatide - solution for injection - teriparatide 250 mcg/ml - teriparatide - teriparatide - treatment of postmenopausal women with osteoporosis at high risk for fracture:forteo is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy. in postmenopausal women with osteoporosis, forteo increases bmd reduces the risk of vertebral and nonvertebral fractures . increase of bone mass in men with primary or hypogonadal osteoporosis at high risk for fracture :forteo is indicated to increase bone mass in men with primary or hypogonadal osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy . treatment of men and women with glucocorticoid-induced osteoporosis at high risk for fracture:forteo is indicated for the treatment of men and women with osteoporosis associated with sustained systemic glucocorticoid therapy (daily dosage equivalent to 5 mg or greater of prednisone) at high risk for fracture, defined as a history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy .

Israel - English - Ministry of Health

abbott medical laboratories ltd, israel - clarithromycin - tablets slow release - clarithromycin 500 mg - clarithromycin - clarithromycin - for treatment of infections caused by susceptible organisms. for lower respiratory tract infections, upper respiratory tract infections, skin and soft tissue infections

Israel - English - Ministry of Health

rafa laboratories ltd - phenoxybenzamine hydrochloride - capsules - phenoxybenzamine hydrochloride 10 mg - phenoxybenzamine - phenoxybenzamine - pheochromocytoma, benign prostatic hypertrophy.

Israel - English - Ministry of Health

neopharm ltd - erythromycin; tretinoin - solution - erythromycin 4 g / 100 g; tretinoin 0.025 g / 100 g - erythromycin, combinations - erythromycin, combinations - all forms of acne, both non-inflammatory forms with comedones and inflammatory forms with papules and pustules, particularly in the case of fat-rich skin.

Israel - English - Ministry of Health

rafa laboratories ltd - morphine sulfate - tablets controlled release - morphine sulfate 100 mg - morphine - morphine - prolonged relief of severe pain.

Israel - English - Ministry of Health

unipharm ltd, israel - fluoxetine as hydrochloride - coated tablets - fluoxetine as hydrochloride 20 mg - fluoxetine - fluoxetine - prizma is indicated for the treatment of depression and obsessive-compulsive disorders (ocd). for the treatment of binge-eating and vomiting behaviors in bulimia nervosa.

Israel - English - Ministry of Health

unipharm ltd, israel - fluoxetine as hydrochloride - tablets - fluoxetine as hydrochloride 60 mg - fluoxetine - fluoxetine - prizma is indicated for the treatment of depression and obsessive-compulsive disorders (ocd). for the treatment of binge-eating and vomiting behaviors in bulimia nervosa.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - eplerenone - film coated tablets - eplerenone 25 mg - eplerenone - inspra is indicated, in addition to standard therapy including beta-blockers, to reduce the risk of cardiovascular mortality and morbidity in stable patients with left ventricular dysfunction (lvef < or = 40 % ) and clinical evidence of heart failure after recent myocardial infarction.inspra is indicated in addition to standard optimal therapy, to reduce the risk of cardiovascular morbidity and mortality in adult patients with nyha class ii (chronic) heart failure and left ventricular systolic dysfunction (lvef < or = 30%).

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - eplerenone - film coated tablets - eplerenone 50 mg - eplerenone - inspra is indicated, in addition to standard therapy including beta-blockers, to reduce the risk of cardiovascular mortality and morbidity in stable patients with left ventricular dysfunction (lvef < or = 40 % ) and clinical evidence of heart failure after recent myocardial infarction.inspra is indicated in addition to standard optimal therapy, to reduce the risk of cardiovascular morbidity and mortality in adult patients with nyha class ii (chronic) heart failure and left ventricular systolic dysfunction (lvef < or = 30%).